Skip to content

Intra-articular Injection in the Knee of Adipose Derived Stromal Cells and Platelet Rich Plasma for Osteoarthritis

Intra-articular Injection in the Knee of Adipose Derived Stromal Cells and Platelet Rich Plasma for Osteoarthritis

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03089762
Enrollment
10
Registered
2017-03-24
Start date
2012-02-12
Completion date
2014-12-30
Last updated
2017-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Brief summary

Stromal vascular fraction (SVF) can easily be obtained from a mini-lipoaspirate procedure of fat tissue and platelet rich plasma (PRP) can be obtained from peripheral blood. Evaluated the safety and preliminary efficacy of administering SVF and PRP intra-articularly into patients with osteoarthritis grade 1 and 2.

Interventions

BIOLOGICALIntra-articular injection of SVF plus PRP

administering SVF and PRP intra-articularly into patients with osteoarthritis grade 1 and 2

Sponsors

Anupam Hospital
CollaboratorOTHER
RegennMed Research and Therapeutics Delhi
CollaboratorUNKNOWN
Bioheart, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients age 50 or older who present with symptomatic primary osteoarthritis of the knee * daily pain for the previous 3 months * analgesics usage at least once a week * less than 30 minutes of morning stiffness * WOMAC score of ≤ 75 in the target knee * Brandt Radiographic Grading Scale of Osteoarthritis grade 1 and 2

Exclusion criteria

* evidence of secondary knee osteoarthritis * severe osteoarthritis (Joint space width - JSW \< 2 mm) * prior intra articular injections within the previous one year prior to inclusion * patients with clinically significant systemic disease

Design outcomes

Primary

MeasureTime frame
WOMAC (Western Ontario and McMaster Universities Arthritis Index)1 year

Secondary

MeasureTime frame
Six minute walk distance1 year

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026